🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Cullinan Therapeutics, Inc.

CGEM Healthcare
$9.04 $-0.24 (-2.53%)
Market Cap: $586.89 M
Gurus Holding
5
Popularity Rank
#1680
% of Shares Held
2.78%
Net Activity (Q3 2026)
+$8.56 M

Guru Ownership Trend

Guru Analysis for Cullinan Therapeutics, Inc. (CGEM)

Cullinan Therapeutics, Inc. (CGEM), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q3 2026, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $16.3 M.

Top institutional holders include Ken Fisher and Cliff Asness.

Institutional sentiment is currently Bullish. This is evidenced by a $8.56 M net inflow during the quarter.

Recent activity highlights Ken Fisher who dramatically increased their stake. Conversely, Cliff Asness reduced exposure by 14.2%.

Key Holders

Recent Activity Breakdown (Q3 2026)

+$11.89 M
Total Buy Value
New Buys 0
Additions 2
-$3.33 M
Total Sell Value
Reductions 3
Sold Out 1

Guru Consensus (Q3 2026)

Based on recent activity
Net Sellers
4
Net Buyers
2

FAQs for Cullinan Therapeutics, Inc. (CGEM)

Major holders include Ken Fisher ($12.29 M), Cliff Asness ($7.65 M), Renaissance Technologies (RenTech) ($4.45 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 1.8 M shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $8.56 M, with 2 managers increasing positions and 4 managers reducing holdings.

During the most recent reporting period, 3 managers trimmed their positions, while 1 fully exited CGEM. The total reported sell value was $3.33 M.

Yes, 0 managers opened new positions in CGEM, and 2 increased their existing holdings. The total reported buy value was $11.89 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.00% Add 2125.0% 800,961 $12.29 M Q3 2026
0.00% Reduce -14.2% 498,566 $7.65 M Q3 2026
0.01% Reduce -11.3% 290,011 $4.45 M Q3 2026
0.05% Reduce -4.6% 181,306 $2.78 M Q3 2026
0.00% Add 42.9% 32,176 $493,902 Q3 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form